Poverty and Discrimination on the Rise for Disabled People: Leonard Cheshire Disability Report
4th November 2009 LONDON, November 4 /PRNewswire/ -- Poverty and discrimination experienced by disabled people is on the rise,
according to a survey conducted by Leonard Cheshire Disability.
In its annual...
ThromboGenics NV - Q3 2009 Business Update
4th November 2009 LEUVEN, Belgium, November 4 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical
company focused on innovative medicines for eye disease, vascular disease and
cancer, is...
MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
3rd November 2009 WILMINGTON, Delaware, November 3 /PRNewswire/ -- The new market research report, 'Global Stem Cell and Advanced
Technologies Market' (2009 - 2014)', published by...
Christmas Shopping 2009: Will the British be Deterred by Swine Flu?
3rd November 2009 LONDON, November 3 /PRNewswire/ -- Twenga, the comprehensive shopping search engine, today reveals further
results from its annual Christmas Spending Survey. The company asked over
3000 Europeans...
/C O R R E C T I O N -- CeloNova BioSciences, Inc./
31st October 2009 NEWNAN, Georgia, October 31 /PRNewswire/ -- In the news release, French Physicians to Conduct 2000-Patient Study of
CATANIA(TM) Coronary Stent, issued Oct. 30, 2009, by CeloNova
BioSciences, Inc.,...
French Physicians to Conduct 2000-Patient Study of CATANIA(TM) Coronary Stent
30th October 2009 NEWNAN, Georgia, October 30 /PRNewswire/ -- Physicians at more than 40 centers in France have joined a study of the
CATANIA(TM) Coronary Stent with NanoThin Polyzene(R)-F manufactured by
CeloNova...
Global Phase III Study Results Show Eribulin Meets Primary Endpoint Of Overall Survival
30th October 2009 LONDON, October 30 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito)
today announced preliminary results from a recently completed Phase III study
with E7389...
Whitepaper From Mirial Explains how Visual Communication Technology can Improve Healthcare Services
29th October 2009 MILAN, October 29 /PRNewswire/ -- Mirial has just released a new whitepaper, An Interactive Visual
Communication Architecture Proposal For Telehealth, which explains in details
the benefits of...
"My Beautiful Face" - The Next Chapter
29th October 2009 LONDON, October 29 /PRNewswire/ -- In a frank commentary, pioneering surgeon to the courageous Katie Piper,
Mr Mohammad Jawad discusses the next challenge he faces in the complex and
vital ongoing...
The Countdown to Christmas - The realbuzz.com Guide to a Healthier You!
28th October 2009 LONDON, October 28 /PRNewswire/ -- Even though no-one wants to admit it, the countdown to Christmas is upon
us, and if you want to look good at the ubiquitous Christmas Party then
follow the...
Kwik-Fit Insurance Staff "Rock the Boat" for Kidney Research
27th October 2009 GLASGOW, October 27 /PRNewswire/ -- Big hearted staff at Kwik Fit Insurance held a charity benefit
concert on Friday night for their charity of the year, Kidney Research UK.
The event at 'The Ferry'...
Promise of Multiple Benefits Underlines the Growing Popularity of Lab-on-chip and Microfluidics, Says Frost & Sullivan
27th October 2009 LONDON, October 27 /PRNewswire/ -- Microfluidics and lab-on-chip is a field with tremendous growth
potential. As it is primarily an enabling technology, coupled with the fact
that this is an era of...
World's Top 50 Most Attractive Employers: Google Followed by Microsoft
27th October 2009 STOCKHOLM, October 27 /PRNewswire/ -- Universum, the employer branding company, presents the world's
Top 50 most attractive employers. From the world's leading economies, nearly
120,000 students at...
Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR
27th October 2009 PARIS, October 27 /PRNewswire/ -- Diabetic patients diagnosed with peripheral neuropathy had lower medical
costs and reduced use of anticonvulsant medications when treated with a
folate-enriched...
Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon
23rd October 2009 LOUISVILLE, Kentucky, October 23 /PRNewswire/ -- -- Alcon takes over development of POT-4 as a treatment for patients with
age-related macular degeneration
-- Deal provides path for Alcon to...
Cohera Medical, Inc. Receives Approval To Begin Human Clinical Trials of TissuGlu(R) in Europe
23rd October 2009 PITTSBURGH, October 23 /PRNewswire/ -- Cohera Medical, Inc. announced today that it has received approval to
begin human clinical trials of its lead product TissuGlu(R) in Germany.
Receipt of the...
MarketsandMarkets: Global H1N1 2009 Influenza Vaccine Market Worth US$ 7,028 Million By 2011
22nd October 2009 WILMINGTON, Delaware, October 22 /PRNewswire/ -- A new market research report, 'Global H1N1 2009 Influenza
Vaccine', published by MarketsandMarkets (http://www.marketsandmarkets.com)
analyzes the...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
